| 证券代码 | MSLI.O |
| 证券名称 | Merus Labs International Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2000-06-06 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | CAD |
| 公司名称 | Merus Labs International Inc. |
| 注册地址 | 加拿大不列颠哥伦比亚省 |
| 办公地址 | 100 Wellington St. West, Suite 2110, Toronto, Ontario, Canada |
| 成立日期 | 2011-12-19 |
| 董事会主席 | Michael Cloutier |
| 公司属地 | Canada 加拿大 |
| 公司网址 | www.meruslabs.com |
| 电话 | +1 (416) 593-3725 |
| 传真 | +1 (416) 593-4434 |
| 公司简介 | Merus Labs International Inc. strategy is driven by an entrepreneurial spirit, coupled with a highly disciplined approach. This allows Merus Labs to acquire and optimize legacy pharmaceuticals and new specialty medicines in a number of therapeutic categories. Merus Labs has a specific focus on Europe, where the company have built a strong pan-European platform, covering the full continent. As well, Merus Labs sells products in four countries outside Europe, including Canada, Australia, South Korea and Mexico. |